Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Global Fund

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Global Fund Releases Funding Recommendations For Transitional Funding Mechanism

“The Global Fund to Fight AIDS, Tuberculosis and Malaria [on Monday] released the funding recommendations of its Technical Review Panel for the Transitional Funding Mechanism,” the Stop TB Partnership reports in an article on its webpage. “Grant proposals for tuberculosis (TB) received 25 percent ($127.4 million) of all the approved funding ($510 million) — a marked increase over the historic average share of 16 percent since the Global Fund was established in 2002,” the article notes, adding, “TB applications were also most successful, with an 86 percent recommendation rate; malaria applications engendered a 79 percent recommendation rate and HIV proposals a 62 percent recommendation rate” (8/21).

U.S. Support Of PEPFAR, Global Fund Helping To Achieve Global AIDS, TB, Malaria Goals

In this post in Huffington Post’s “Impact” blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, examines “the success of U.S. efforts to promote better global health through support for [PEPFAR] and the Global Fund to Fight AIDS, Tuberculosis and Malaria.” She highlights U.S. Secretary of State Hillary Clinton’s recent trip to Africa, writing that Clinton’s “encouraging words” at the Reach Out Mbuya health center in Uganda reinforced U.S. commitment to an AIDS-free generation. She notes both PEPFAR and the Global Fund have supported the center and adds that “through hundreds of similar local programs all over the world, the Global Fund provides treatment to 3.6 million people who are HIV-positive.”

IRIN Examines Administration Of Methadone As Treatment For People Who Inject Drugs In Bangladesh

“Methadone treatment is proving to be the most efficient way to wean people in Bangladesh from addiction to buprenorphine, a pharmaceutical drug, and health experts say it should be expanded to reach thousands more drug users to prevent the spread of HIV,” IRIN reports. The news service notes that “illegal use of pharmaceutical substances, mostly buprenorphine, is on the rise” in the country. “Buprenorphine was intended to be used to wean injecting drug users, also known as people who inject drugs (PWID), from narcotics like heroin, but has itself become a substance of addiction, with users injecting a liquid form of it,” the news service notes, adding, “Methadone, a pain reliever, suppresses withdrawal symptoms and blocks craving.”

Global Fund, Nigeria Sign Agreements Worth $225M To Prevent, Treat Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria and the Nigerian government on Friday “signed two grant agreements … worth a total of $225 million to support programs that will prevent and treat malaria,” a Global Fund press release reports. According to the press release, the agreements “include an additional $50 million for bed nets, approved in an unusual move by the Global Fund Board that was linked to additional commitments by the government of Nigeria” (8/24). Global Fund Deputy Executive Director Debrework Zewdie “told top government functionaries that the [money] is meant to assure the international community that Nigeria is a worthy partner in the fight to eradicate malaria,” ThisDay writes, adding, “During a transformation of the fund’s grant management structure this year, Nigeria was identified as one of the 20 ‘high impact’ countries that are now receiving special attention” (8/26). Aigboje Aig-Imoukhuede, CEO of Access Bank and chair of the Friends of the Global Fund Africa, “described the grant as [an] opportunity for Nigeria to show leadership and commitment in the fight against malaria by committing more resources to save lives,” the Daily Trust notes (Atonko, 8/26).

Blog Examines Use Of Controversial HIV Drug In Malawi

This post in the Center for Global Health Policy’s “Science Speaks” blog examines the use of stavudine, “also known as d4T, an antiretroviral treatment that was dropped in wealthy countries years ago and that the World Health Organization has recommended stop being included in treatment programs,” to treat HIV in Malawi. “[W]hile children and pregnant or breastfeeding women, as well as tuberculosis patients have access to less toxic treatments, stavudine continues to be the first treatment supplied to most Malawi patients under the terms of the country’s grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria,” the blog writes, adding, “In a letter [.pdf] to Global Fund General Manager Gabriel Jaramillo and [U.S. Global AIDS Coordinator Ambassador] Eric Goosby, the Centre for Development of People (CEDEP), Health GAP (Global Access Project), and the Malawi Network of People Living with HIV/AIDS (MANET+) are asking the Global Fund to find a way to switch to first line treatment in Malawi that is acceptable to patients and World Health Organization standards” (8/15).

Aidspan Publishes New Issue Of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund, on Wednesday published Issue 192 of its “Global Fund Observer.” The issue features an article examining new reports released by the Office of the Inspector General on three audits and four diagnostic reviews; an article highlighting two reports on the impact of the cancellation of Round 11 by the Global Fund; and an article discussing the reaction to Spain’s Global Fund contribution, among others (8/15).

CSIS Report Examines HIV Prevention, Care Among People Who Inject Drugs In Ukraine

A new report, titled “Injection Drug Use in Ukraine” and published by the Center for Strategic & International Studies (CSIS), examines the challenges of providing HIV prevention and care services in the country, particularly to people who inject drugs (PWID), who accounted for “nearly 50 percent of new HIV infections registered in 2010,” according to the CSIS website. Authors Phillip Nieburg, senior associate and co-chair of the Prevention Committee of the CSIS HIV/AIDS Task Force, and Lisa Carty, senior adviser in the CSIS Global Health Policy Center, also examine how the Global Fund to Fight AIDS, Tuberculosis and Malaria and PEPFAR could help Ukraine “in advancing HIV prevention and other services for PWID,” the website notes (3/16).

Swazi, South African Activists March To U.S. Consulate In Johannesburg To Call For Emergency Global Fund Meeting

“Almost a thousand Swazi and South African HIV activists marched to the United States consulate in Johannesburg on [Thursday] to demand that the U.S. continue supporting the Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria, and safeguard funding of its President’s Emergency Plan for AIDS Relief (PEPFAR),” PlusNews reports. “The march organizers — a coalition of international and regional HIV organizations, including the global medical charity Medecins Sans Frontieres (MSF), the World AIDS Campaign, and the AIDS Rights Alliance Southern Africa — also called on the British and Australian governments to join their American counterparts in kick-starting a response to solve the Global Fund’s financial crisis,” according to the news service.

NGOs Release Joint Statement Calling For Governments To Increase Payments To Global Fund To Fill Gap In TB Funding

Ahead of World Tuberculosis (TB) Day on March 24, three non-governmental organizations (NGOs) released a joint statement warning that “[a] $1.7 billion funding shortfall to fight [TB] over the next five years means 3.4 million patients will go untreated and gains made against the disease will be reversed,” Reuters reports. The International HIV/AIDS Alliance, the Stop AIDS Campaign and Results UK said in the statement that the cancellation of Round 11 grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria was endangering the expansion of treatment and prevention programs, the news agency notes. The statement “called on governments to scale up funding of TB, HIV and malaria programs at a G20 meeting in Mexico in June in an effort to replenish the Global Fund with $2 billion,” according to Reuters (Mollins, 3/23).

Global Fund Donors ‘Earmark’ Funds For Capacity-Building, Fund’s General Manager Says

Gabriel Jaramillo, the general manager of the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria, said in an interview on Friday that “quite a few donors” to the fund “have earmarked portions of their donations to us, their contributions, to capacity-building,” the Associated Press/Washington Post reports. According to the AP, the Global Fund “is increasingly being forced to devote a portion of its donations to improving its own spending controls rather than disease-fighting,” the news service writes. “France, whose nearly $2.9 billion in donations have made it the fund’s second-largest contributor after the U.S., will sign a new pledging agreement this month requiring that five percent of its money go to tighten financial accountability among grant recipients, he said,” the AP writes.